SCHEMBL3494898

SCHEMBL3494898

CCSc1ccc(S(=O)(=O)O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 6/20 0.47
CA12 O43570 2/20 0.47
CA1 P00915 2/20 0.47
CA7 P43166 2/20 0.47
CA13 Q8N1Q1 2/20 0.47
LMNA P02545 1/20 0.46
TSHR P16473 2/20 0.45
ALDH1A1 P00352 2/20 0.45
NT5E P21589 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.43
MEN1 O00255 1/20 0.42
HSP90AA1 P07900 1/20 0.42
CYP2C9 P11712 1/20 0.42
HPGD P15428 1/20 0.42
CYP2C19 P33261 1/20 0.42
KMT2A Q03164 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
SLC6A4 P31645 6/20 0.41
MAOA P21397 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14351687 0.83 CA2 (0.50) CA2CA12CA1CA7CA13
SCHEMBL28772561 0.79 LMNA (0.46) CA2CA12CA1CA7CA13
SCHEMBL29131214 0.79 CA2 (0.47) CA2CA12CA1CA7CA13
SCHEMBL25384705 0.79 CA2 (0.45) CA2CA12CA1CA7CA13
SCHEMBL10884986 0.77 TSHR (0.47) CA2CA1CA7TSHRALDH1A1
SCHEMBL346860 0.76 SLC6A4 (0.56) CA2CA12CA1CA7CA13
SCHEMBL7998600 0.76 CA2 (0.49) CA2CA12CA1CA7CA13
SCHEMBL11193014 0.76 ALDH1A1 (0.44) LMNATSHRALDH1A1SMN1; SMN2MEN1
SCHEMBL1892147 0.76 TSHR (0.55) LMNATSHRALDH1A1NT5ESMN1; SMN2
SCHEMBL979380 0.75 LMNA (0.56) CA2CA12CA1CA7CA13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115023782-A Electrolytic capacitor 松下知识产权经营株式会社 2022-09-06 CN disclosed
CN-108713233-B Electrolytic capacitor 松下知识产权经营株式会社 2021-08-06 CN disclosed
US-10937599-B2 Electrolytic capacitor PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2021-03-02 US disclosed
US-20200234889-A1 ELECTROLYTIC CAPACITOR PANASONIC IP MAN CO LTD (JP) 2020-07-23 US disclosed
US-10643795-B2 Electrolytic capacitor PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2020-05-05 US disclosed
EP-2589701-B1 METHOD FOR PRODUCING SIZING AGENT-COATED CARBON FIBERS, AND SIZING AGENT-COATED CARBON FIBERS TORAY INDUSTRIES (JP) 2019-08-21 EP disclosed
US-10251392-B2 Antimicrobial devices and compositions AVENT, INC. (US) 2019-04-09 US disclosed
US-10251392-B2 Antimicrobial devices and compositions AVENT, INC. (US) 2019-04-09 US disclosed
US-10184034-B2 Carbon fiber forming raw material, formed material, and carbon fiber-reinforced composite material TORAY INDUSTRIES, INC. (JP) 2019-01-22 US disclosed
US-20190006111-A1 ELECTROLYTIC CAPACITOR PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2019-01-03 US disclosed
EP-2765155-A1 CARBON FIBER-REINFORCED THERMOPLASTIC RESIN COMPOSITION, MOLDING MATERIAL, PREPREG, AND METHODS FOR PRODUCING SAME Toray Industries, Inc. (JP) 2014-08-13 EP disclosed
EP-2698802-A1 Electrolytic capacitor comprising a separtor comprising a conductive polymer containing a p-dopant on its surface Panasonic Corporation (JP) 2014-02-19 EP disclosed
EP-2589701-A1 METHOD FOR PRODUCING SIZING AGENT-COATED CARBON FIBERS, AND SIZING AGENT-COATED CARBON FIBERS Toray Industries, Inc. (JP) 2013-05-08 EP disclosed
US-20130089736-A1 METHOD FOR PRODUCING SIZING AGENT-COATED CARBON FIBERS, AND SIZING AGENT-COATED CARBON FIBERS TORAY INDUSTRIES, INC. (JP) 2013-04-11 US disclosed
US-7859828-B2 supresses increase in the ESR (equivalent series resistance) with the elapse of time in an electrolytic capacitor is suppressed PANASONIC CORPORATION (JP) 2010-12-28 US disclosed
US-20090035342-A1 Antimicrobial Devices and Compositions AVANOS MEDICAL SALES, LLC 2009-02-05 US disclosed
US-20090035342-A1 Antimicrobial Devices and Compositions AVANOS MEDICAL SALES, LLC 2009-02-05 US disclosed
US-20090035342-A1 Antimicrobial Devices and Compositions AVANOS MEDICAL SALES, LLC 2009-02-05 US disclosed
US-20080316679-A1 Electrolytic Solution for Electrolytic Capacitor, and Electrolytic Capacitor Using the Same PANASONIC CORPORATION (JP) 2008-12-25 US disclosed
EP-1808875-A1 ELECTROLYTE FOR ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR UTILIZING THE SAME MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2007-07-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10251392-B2 Antimicrobial devices and compositions AAAS, AOC1, COL14A1 CA2 561/4885CA12 923/4885CA1 484/4885
US-20090035342-A1 Antimicrobial Devices and Compositions AAAS, AOC1, COL14A1 CA2 561/4885CA12 923/4885CA1 484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.